TRANS-ACTIVATION OF GLOBIN PROMOTERS BY SV40 T-ANTIGEN AND ADENOVIRUS EIA
TRANS-ACTIVATION OF GLOBIN PROMOTERS BY SV40 T-ANTIGEN AND ADENOVIRUS EIA
批准号:
3940481
负责人:
S X CAO
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Regulation of gene expression in eukaryotic cells is largely
controlled at the level of transcription. This control is mediated
by interactions of transacting factors and cis-regulatory
sequences. To gain some insights into the mechanisms of trans-
activation, we have undertaken studies to examine the ability of
two viral early gene products, T antigen of SV40 and E1A protein
of adenovirus, to trans-activate human globin gene promoters.
Since T antigen and E1A possess both similar and distinct
properties in gene regulation, we thought it is important to know
the relationship between the two viral proteins in trans-activation
of gene expression. This may help us to understand the trans-
activation mechanisms of polymerase II transcription in
eukaryotic cells. During the past year, we have compared the
trans-activation effect of T antigen and E1A by co-transfecting a
testing plasmid p-epsilon-GLCAT with either pRSV-T (plasmid
expressing the SV40 T antigen) or pE1A (plasmid expressing the
E1A protein of adenovirus) into CV-1 cells and COS-1 cells. By
transient assay, we found that while both T antigen and E1A
trans-activation. We also demonstrated that T antigen can
produce additional stimulatory effect on p-epsilon-GLCAT-SV
(enhancer+) in CV-1 cells, but E1A has no any effect on this
plasmid. Furthermore, whereas introduction of pRSV-T into COS-
1 cells had no effect on p-epsilon-GLCAT expression, the
presence of pE1A produced great increase in CAT activity,
compared with transfection carried out with p-epsilon-GLCAT
alone. Our results, therefore, suggest that T antigen and E1A
trans-activate the epsilon-globin promoter by using different
mechanisms, probably mediated by different cellular transcription
factors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DNA BINDING PROTEINS IN K562 CELLS
-
批准号:4689453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S X CAO
-
依托单位:
IDENTIFICATION OF A SILENCER ELEMENT IN THE HUMAN EPSILON-GLOBIN GENE
-
批准号:3917583
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S X CAO
-
依托单位:
CHROMATIN STRUCTURE AND TRANS-ACTIVATION OF HUMAN GLOBIN GENES
-
批准号:3964313
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:S X CAO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PCV2茎环结构DNA激活cGAS-STING通路诱导的天然免疫应答的作用研究
-
批准号:2026JJ50413
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王东亮
-
依托单位:
机械力响应型DNA探针用于肿瘤微环境细胞力学可视化与药物筛选研究
-
批准号:2026JJ60135
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨思慧
-
依托单位:
CDC45通过调控DNA复制应激促进肝癌发生发展的机制
-
批准号:2026JJ82714
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵志坚
-
依托单位:
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
-
批准号:JCZRLH202601177
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
-
批准号:2026JJ80500
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:阳帆
-
依托单位:
乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
-
批准号:2026JJ81975
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖娇
-
依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究
-
批准号:2026JJ82371
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王哲享
-
依托单位:
孕期多环芳烃暴露与DNA甲基化改变对子代神经发育影响的出生队列研究
-
批准号:2026JJ81844
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吕玲双
-
依托单位:
Compound 3K抑制NBS1乳酸化修饰增强DNA损伤克服胃癌化疗耐药的作用及机制研究
-
批准号:2026JJ82336
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:綦湘毅
-
依托单位:
WSTF/SNF2H 介导的 DNA 损伤在 DPSCs 衰老中的机制研究
-
批准号:ZCLQN26H1401
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:虞其豪
-
依托单位: